Insider · CIK 0001437911

Warma Neil K

Reports to the SEC for 2 companies · TORONTO

sec.gov

Transactions

Companies

Filings

CIK

0001437911

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-20	PMNProMIS Neurosciences Inc. · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+160K sh	—	—	160,000
2026-02-03	PMNProMIS Neurosciences Inc.A Award	Director, Chief Executive Officer	AAward	+6,183 sh	$12.13	+$75K	6,183
2026-02-03	PMNProMIS Neurosciences Inc. · Warrants to purchase Common SharesA Award	Director, Chief Executive Officer	AAward	+6,183 sh	—	—	6,183
2025-09-22	PMNProMIS Neurosciences Inc. · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+600K sh	—	—	600,000
2024-10-08	PMNProMIS Neurosciences Inc. · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.14M sh	—	—	1,352,455
2024-10-08	PMNProMIS Neurosciences Inc. · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+490K sh	—	—	1,842,739
2024-01-02	PMNProMIS Neurosciences Inc. · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	208,333
2016-05-16	Acer Therapeutics Inc.Employee Stock Option (Right to Buy)A Award	Director, President, CEO and Acting CFO	AAward	+50K sh	—	—	50,000
2015-04-08	Acer Therapeutics Inc.M Exercise/Conversion	Director, President, CEO and Acting CFO	MExercise/Conversion	+37.2K sh	—	—	144,881
2015-04-08	Acer Therapeutics Inc.Subscription Rights (Right to Buy)M Exercise/Conversion	Director, President, CEO and Acting CFO	MExercise/Conversion	−37.2K sh	—	—	0
2015-04-08	Acer Therapeutics Inc.Warrants (Right to Buy)M Exercise/Conversion	Director, President, CEO and Acting CFO	MExercise/Conversion	+37.2K sh	—	—	37,247
2015-03-02	Acer Therapeutics Inc.Employee Stock Option (Right to Buy)A Award	Director, President, CEO and Acting CFO	AAward	+120K sh	—	—	120,000
2014-09-16	Acer Therapeutics Inc.P Purchase	Director, President, CEO and Acting CFO	PPurchase	+10K sh	$1.11	+$11.1K	107,634
2014-02-28	Acer Therapeutics Inc.A Award	Director, President, CEO and Acting CFO	AAward	+51.7K sh	—	—	97,634
2014-02-28	Acer Therapeutics Inc.Employee Stock Option (Right to Buy)A Award	Director, President, CEO and Acting CFO	AAward	+316K sh	—	—	316,250
2013-11-08	Acer Therapeutics Inc.A Award	Director, President, CEO and Acting CFO	AAward	+28.6K sh	—	—	45,886
2013-11-08	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+50K sh	—	—	50,000
2013-09-24	Acer Therapeutics Inc.C Conversion	Director, President, CEO and Acting CFO	CConversion	+8,076 sh	$1.91	+$15.4K	17,315
2013-09-24	Acer Therapeutics Inc.Convertible Promissory NoteC Conversion	Director, President, CEO and Acting CFO	CConversion	—	—	—	0
2013-06-30	Acer Therapeutics Inc.A Award	Director, President, CEO and Acting CFO	AAward	+581 sh	$1.54	+$894.74	9,239
2013-04-29	Acer Therapeutics Inc.A Award	Director, President, CEO and Acting CFO	AAward	+28.6K sh	—	—	37,229
2013-04-29	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+50K sh	—	—	50,000
2013-02-04	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+96K sh	—	—	95,970
2013-02-04	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+96K sh	—	—	95,970
2013-01-29	Acer Therapeutics Inc.Common Stock Warrant (Right to Buy)A Award	Director, President, CEO and Acting CFO	AAward	+688 sh	—	—	688
2012-12-31	Acer Therapeutics Inc.A Award	Director, President, CEO and Acting CFO	AAward	+600 sh	$1.33	+$798	8,658
2012-09-12	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+43.6K sh	—	—	43,623
2012-07-25	Acer Therapeutics Inc.Convertible Promissory NoteA Award	Director, President, CEO and Acting CFO	AAward	—	—	—	150
2012-07-25	Acer Therapeutics Inc.Common Stock Warrant (Right to Buy)A Award	Director, President, CEO and Acting CFO	AAward	+14.1K sh	—	—	14,063
2012-01-06	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+174K sh	—	—	174,493
2011-01-04	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+75K sh	—	—	75,000
2010-06-14	Acer Therapeutics Inc.P Purchase	Director, President, CEO and Acting CFO	PPurchase	+5,000 sh	$1.62	+$8,100	32,234
2010-06-11	Acer Therapeutics Inc.P Purchase	Director, President, CEO and Acting CFO	PPurchase	+3,000 sh	$1.64	+$4,920	27,234
2010-06-09	Acer Therapeutics Inc.C Conversion	Director, President, CEO and Acting CFO	CConversion	+21.2K sh	$0.50	+$10.6K	24,234
2010-06-09	Acer Therapeutics Inc.10% Convertible Promissory Note due April 14, 2011C Conversion	Director, President, CEO and Acting CFO	CConversion	—	—	—	0
2009-11-30	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+100K sh	—	—	100,000
2009-04-14	Acer Therapeutics Inc.Convertible Promissory NoteA Award	Director, President, CEO and Acting CFO	AAward	+20K sh	$0.50	+$10K	423,021
2009-04-14	Acer Therapeutics Inc.Common Stock Warrant (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+10K sh	$0.75	+$7,500	433,021
2009-01-16	Acer Therapeutics Inc.Common Stock Option (right to buy)A Award	Director, President, CEO and Acting CFO	AAward	+150K sh	—	—	403,021

Recent filings

Accepted (ET)
May 224
Warma Neil K0001104659-26-065772
SEC(opens sec.gov)
Feb 54
Warma Neil K0001104659-26-011138
SEC(opens sec.gov)
Sep 244
Warma Neil K0001437911-25-000002
SEC(opens sec.gov)
Oct 104
Warma Neil K0001374339-24-000004
SEC(opens sec.gov)
Jan 54
Warma Neil K0001374339-24-000001
SEC(opens sec.gov)
May 184
Opexa Therapeutics, Inc.0001354488-16-007554
SEC(opens sec.gov)
Apr 94
Opexa Therapeutics, Inc.0001354488-15-001664
SEC(opens sec.gov)
Mar 44
Opexa Therapeutics, Inc.0001140361-15-010221
SEC(opens sec.gov)
Sep 174
Opexa Therapeutics, Inc.0001140361-14-035795
SEC(opens sec.gov)
Mar 44
Opexa Therapeutics, Inc.0001140361-14-010982
SEC(opens sec.gov)
Nov 124
Opexa Therapeutics, Inc.0001140361-13-041531
SEC(opens sec.gov)
Sep 264
Opexa Therapeutics, Inc.0001140361-13-037087
SEC(opens sec.gov)
Jul 24
Opexa Therapeutics, Inc.0001140361-13-027083
SEC(opens sec.gov)

Companies

Address

C/O PROMIS NEUROSCIENCES INC. SUITE 200, 1920 YONGE STREET

TORONTO, M4S 3E2